Journal Home
Search for

Volume 583, Issue 1, Pages 19-24 (5 January 2009)


View previous. 5 of 45 View next.

FGF21 N- and C-termini play different roles in receptor interaction and activation

Edited by Gianni Cesareni

Junming YieaCorresponding Author Informationemail address, Randy Hechtb, Jennifer Patela, Jennitte Stevensb, Wei Wangb, Nessa Hawkinsb, Shirley Steavensonb, Steve Smithb, Dwight Wintersb, Seth Fisherb, Ling Caib, Ed Belouskib, Ching Chenb, Mark L. Michaelsb, Yue-Sheng Lib, Richard Lindberga, Minghan Wanga, Murielle Vénianta, Jing Xua

Received 11 September 2008; received in revised form 20 October 2008; accepted 9 November 2008. published online 05 December 2008.

Abstract 

Fibroblast growth factor-21 (FGF21) signaling requires the presence of β-Klotho, a co-receptor with a very short cytoplasmic domain. Here we show that FGF21 binds directly to β-Klotho through its C-terminus. Serial C-terminal truncations of FGF21 weakened or even abrogated its interaction with β-Klotho in a Biacore assay, and led to gradual loss of potency in a luciferase reporter assay but with little effect on maximal response. In contrast, serial N-terminal truncations of FGF21 had no impact on β-Klotho binding. Interestingly, several of them exhibited characteristics of partial agonists with minimal effects on potency. These data demonstrate that the C-terminus of FGF21 is critical for binding to β-Klotho and the N-terminus is critical for fibroblast growth factor receptor (FGFR) activation.

Structured summary

MINT-6799939: FGFR1c (uniprotkb:P11362) binds (MI:0407) to β-Klotho (uniprotkb: Q86Z14) by surface plasmon resonance (MI:0107)

MINT-6799907, MINT-6799922: FGF21 (uniprotkb: Q9NSA1) binds (MI:0407) to β-Klotho (uniprotkb: Q86Z14) by surface plasmon resonance (MI:0107)

a Department of Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Mail Stop 29-1-A, Thousand Oaks, CA 91320, USA

b Department of Protein Science, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA

Corresponding Author InformationCorresponding author. Fax: +1 805 499 0953.

PII: S0014-5793(08)00935-6

doi:10.1016/j.febslet.2008.11.023


View previous. 5 of 45 View next.